Leila Boustany
About Leila Boustany
Leila Boustany serves as Associate Director at CytomX Therapeutics, where she has worked since 2019. With a strong background in biologics and significant experience in assay development, she has held various roles in the biotechnology industry, including a Principal Scientist position at Pfizer, Inc.
Work at CytomX Therapeutics
Leila Boustany has been with CytomX Therapeutics since 2015, where she has held various positions, including Senior Scientist I, Senior Scientist II, and currently, Associate Director. In her role as Associate Director, she has contributed to the development of innovative therapies, particularly in the area of T cell bispecifics. Her tenure at CytomX spans over eight years, during which she has played a significant role in advancing the company's research initiatives.
Education and Expertise
Leila Boustany holds a Doctor of Philosophy (Ph.D.) in Biological Sciences from Stanford University, which she completed from 1996 to 2002. She also earned a Bachelor's Degree in Biological Sciences from Carleton College, graduating in 1994. Her educational background supports her expertise in developing T cell bispecifics and assay development, which are essential in the field of biologics and preclinical drug discovery.
Background
Before joining CytomX Therapeutics, Leila Boustany worked at Pfizer, Inc. Rinat Labs for seven years, from 2008 to 2015, where she held the position of Principal Scientist. She also served as a Senior Scientist at the same organization from 2006 to 2008. Her experience at Pfizer provided her with a solid foundation in biologics and drug development, particularly in South San Francisco, CA.
Achievements
Leila Boustany has significant experience in assay development and optimization, which has contributed to advancements in preclinical drug discovery. She has a strong background in flow cytometry, a critical technique for cell-based assays. Additionally, she has led multiple external collaborations, demonstrating her capability to work effectively across organizational boundaries and enhance research outcomes.